| |
| |
|
| Insider
Information: |
Lewis-Hall Freda C |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
715,557 |
|
|
Indirect Shares
|
4,598,167 |
|
|
| Direct
Value |
$35,409,314 |
|
|
|
Indirect Value
|
$119,966 |
|
|
| Total
Shares |
5,313,724 |
|
|
| Total
Value |
$35,529,281 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Medicines Develop... |
2009-03-19 |
53,334 |
2008-06-18 |
0 |
Premium* |
|
|
Pfizer Inc |
PFE |
Executive Vice President |
2019-02-27 |
375,244 |
2019-02-27 |
4,320 |
Premium* |
|
|
Tenet Healthcare Corp |
THC |
Director |
2016-05-13 |
15,314 |
2014-12-24 |
0 |
Premium* |
|
|
Springworks Therapeutics, Inc. |
SWTX |
Director |
2023-05-24 |
10,572 |
2019-09-17 |
4,593,847 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
19,688 |
2020-04-22 |
0 |
Premium* |
|
|
Pyxis Oncology, Inc. |
PYXS |
|
2024-03-26 |
241,405 |
2022-03-31 |
0 |
Premium* |
|
|
1life Healthcare Inc |
ONEM |
|
2023-02-22 |
0 |
2022-06-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONEM |
1life Healthcare Inc |
|
– • – |
2023-02-22 |
4 |
D |
$18.00 |
$81,612 |
D/D |
(4,534) |
0 |
0 |
- |
|
| THC |
Tenet Healthcare Corp |
Director |
– • – |
2014-12-24 |
4 |
A |
$52.44 |
$136,764 |
D/D |
2,608 |
2,608 |
0 |
- |
|
| ONEM |
1life Healthcare Inc |
|
– • – |
2022-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,534 |
4,534 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2020-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,064 |
5,064 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,818 |
5,924 |
0 |
- |
|
| THC |
Tenet Healthcare Corp |
Director |
– • – |
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,722 |
7,330 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2020-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,408 |
8,472 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,011 |
10,483 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,648 |
10,572 |
0 |
- |
|
| THC |
Tenet Healthcare Corp |
Director |
– • – |
2016-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,984 |
15,314 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,606 |
16,089 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,599 |
19,688 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,106 |
25,227 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Development |
• – – |
2008-12-19 |
4 |
AS |
$29.90 |
$37,375 |
D/D |
(1,250) |
42,500 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Development |
• – – |
2008-12-11 |
4 |
AS |
$26.00 |
$28,548 |
D/D |
(1,098) |
43,750 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Development |
• – – |
2008-12-10 |
4 |
AS |
$26.00 |
$3,952 |
D/D |
(152) |
44,848 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Development |
• – – |
2008-06-18 |
4 |
A |
$0.01 |
$450 |
D/D |
45,000 |
45,000 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Development |
• – – |
2009-03-19 |
4 |
AS |
$29.11 |
$36,388 |
D/D |
(1,250) |
53,334 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Development |
• – – |
2009-02-05 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
54,584 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2009-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
65,833 |
65,833 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
|
• • – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
66,831 |
66,831 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,070 |
92,862 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2014-02-24 |
4 |
D |
$31.99 |
$581,418 |
D/D |
(18,175) |
101,531 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2014-02-26 |
4 |
D |
$31.99 |
$562,320 |
D/D |
(17,578) |
118,038 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2013-09-16 |
4 |
S |
$28.70 |
$1,103,831 |
D/D |
(38,461) |
118,383 |
0 |
- |
|
58 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
